傲農生物(603363.SH):擬開展套期保值業務
格隆匯4月2日丨傲農生物(603363.SH)公佈,公司於2020年4月2日召開第二屆董事會第二十二次會議,審議通過了《關於公司開展套期保值業務的議案》,同意公司開展套期保值業務。
公司從事商品期貨、期權交易套期保值,主要是通過買入(賣出)與現貨市場數量相當、但交易方向相反的期貨或者期權合約,以達到以一個市場的盈利來彌補另一個市場的虧損,從而規避價格波動風險的目的。
擬投資的期貨、期權品種:商品期貨交易所掛牌交易的玉米、小麥、大豆、豆粕、豆油等產品期貨合約以及金融衍生品市場的場外期權合約。
擬投入的資金金額:預計在套期保值業務期間內,公司對飼料原料套保累計數量不超過100萬噸,套期保值業務期間任一時點所佔用保證金(包括後續可能要追加的保證金)最高資金限額為人民幣3000萬元(不含期貨標的實物交割款項)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.